THE INTERNATIONAL MENOPAUSE SOCIETY
The object of IMS is to promote and co-ordinate information, education and scientific studies of the health and well-being of peri- and post-menopausal women during and after mid-life.
Financial health, per its FY2024 accounts
The charity reported an in-year surplus of £41,829 for the year ended 31 December 2024, with total unrestricted funds at year-end amounting to £1,647,346. The trustees confirmed that free reserves were sufficient to meet their stated policy target of one year's operating costs plus additional contingency funds. The accounts were subject to an independent examination rather than a full audit.
What the accounts disclose
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Dr NICOLAS PANAYchair
- Assoc Prof Amanda Vincent
- Dr Ang Seng Bin
- Dr Antonio Cano Sanchez
- Dr Marla Shapiro C.M.
- Dr Nicole Gusti Jaff
- Dr Peter Chedraui
- Dr Peter Schnatz
- Dr Premitha Damodaran
- Dr Steven Goldstein MD NCMP
- Dr Sunila Khandelwal
- Dr Timothy Hillard
- Dr Wendy Wolfman
- Prof Pauline Maki PhD
- Prof Rossella Nappi MD, PHD
- Prof Santiago Palacios MD PhD
- Prof Tommaso Simoncini
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £669k | £736k |
| 31/12/2023 | £278k | £523k |
| 31/12/2022 | £675k | £412k |
| 31/12/2021 | £496k | £247k |
| 31/12/2020 | £280k | £443k |
Common questions
Is THE INTERNATIONAL MENOPAUSE SOCIETY financially healthy?
Per its FY2024 accounts: The charity reported an in-year surplus of £41,829 for the year ended 31 December 2024, with total unrestricted funds at year-end amounting to £1,647,346. The trustees confirmed that free reserves were sufficient to meet their stated policy target of one year's operating costs plus additional contingency funds. The accounts were subject to an independent examination rather than a full audit. Its FY2024 accounts were independently examined.